By B.N. Frank
COVID-19 is certainly nothing to sneeze at. Neither are the reports about the people testing positive who really weren’t. Only time will tell how accurate this new test will be.
Exclusive: First full at-home COVID-19 test
Gauss, a computer vision startup, and Cellex, a biotech company that works on diagnostics, are announcing the first rapid COVID-19 test that can be fully performed by people at home without involving a laboratory.
Why it matters: Experts agree that the U.S. still needs far more widespread testing to help contain the coronavirus pandemic. An antigen test that could be performed and provide results rapidly at home could help reduce testing delays and allow people to quickly find out whether they need to isolate because of a COVID-19 infection.
How it works: In the antigen test, which was developed by Cellex, a user will take a nasal swab to both nostrils, and then place the swab in a small vial filled with a buffer solution.
- Four droplets from the tube are placed on a rapid test cassette, and test lines will show up of varying intensity, based on whether and how much virus is in the sample.
- Users will then take a picture of the rapid test, and Gauss’s app will use AI to deliver back the results — all within 15 minutes.
In a perfect world, The FDA would have a laudable history of approving only products that were safe and accurate. Unfortunately, they don’t (see 1, 2, 3, 4, 5, 6, 7) and have even been blamed for “igniting” the Opioid Crisis.
Other products being considered for the regulatory agency’s approval include biosensors implanted under the skin to detect illness, and computer chips implanted inside human heads that were described by manufacturer Elon Musk as “a Fitbit in the skull.”
Activist Post reports regularly about invasive and unsafe technology. For more information visit our archives.
Provide, Protect and Profit from what’s coming! Get a free issue of Counter Markets today.